Whether you’ve already been diagnosed, or you want to know your risk, health experts can test your DNA to determine your chances of developing cancer.
“The testing itself determines whether or not they have inherited this broken gene that could … Read more
The US Food and Drug Administration (FDA) has approved a cancer diagnostic test, FoundationOne CDx (F1CDx, Foundation Medicine), for use in detecting 300-plus genetic mutations in any solid tumor. At the same time, the Centers for Medicare & Medicaid Services … Read more
By: Annette McElhiney
Now that it is December, most of us are preparing for the holidays. We plan and host parties, we prepare special foods, we give presents, and we create a “wish list” for ourselves. I’ve said many times … Read more
By: Rick Boulay
sur•vi•vor (sərˈvīvər/) noun : A person who is able to live their life despite experiencing difficulties.
“I can’t wait to get through my cancer treatment so I can go on living my life. I want to be … Read more
By: Leslie Barker
Gratitude tends to be, at its most basic, two words: Thank you.
It can also be a list (the colors of autumn, extra-hot coffee, a purring cat, a laughing baby). It can be a hand-written … Read more
Early studies are showing promise for immunotherapy agents such as checkpoint inhibitors in the treatment field of ovarian cancer, according to Jonathan Ledermann, M.D.
One such study is JAVELIN Ovarian 200, a study of Bavencio (avelumab) alone or in combination … Read more
By: Susan Gubar
Looking at television this past year, I sobbed at the sight of Nazis on the streets of Charlottesville. I don’t remember crying over the terrible cancer diagnosis back in 2008. Living with the disease for almost a … Read more
A newly studied blood test could be the answer to a serious question: How can a woman tell if she has ovarian cancer in its earliest stage?
Currently, there are no approved screening techniques from the Food and Drug Administration … Read more
One in five patients with ovarian cancer said that they would not be willing to travel an additional 50 miles for cancer care for only a 6% 5-year survival benefit, according to the results of a study published in Gynecologic … Read more
Anne Hermiller and Sarah Ludinich experienced ovarian cancer at different stages in life. What’s similar is their passion for making other women more aware of the disease and its effects.
Hermiller, of Findlay, learned she had cancer in 2014. “I … Read more
An article published in the Gynecologic Oncology Research and Practice reviews the current medications available for treatment of ovarian cancer.
Epithelial ovarian cancer is commonly diagnosed in its advanced stages. Although current management for ovarian cancer is effective in inducing … Read more
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately. The team has identified a network of circulating microRNAs – small, … Read more
When it comes to cancer types that disproportionately affect women, breast cancer gets a lot of buzz. And by all means, continue your regular self-exams and mammograms, please! Still, it’s important to tune in to the signs of ovarian cancer, … Read more
Platinum/taxane combinations are the most effective regimens for treatment of epithelial ovarian cancer. Response varies between patients, but because the molecular basis for resistance is not defined, patients receive so-called one size fits all therapy. In contrast, elucidation of the … Read more
Many of the most severe ovarian cancer cases may originate in the fallopian tube (FT), based on data from an analysis of nine patients published online in Nature Communications.
“Our data suggest that FT neoplasia is the origin of ovarian … Read more
Anne Cope was never alone.
As the 66-year-old endured chemotherapy while she battled ovarian cancer, she could count on one thing: her children would be there by her side.
Her husband, Nick Milonas, has serious health issues, which prevented him … Read more
Join OCRFA on Monday, Oct. 23rd at 6:00pm ET for a webinar on PARP Inhibitors with Dr. Ursula Matulonis of Dana-Farber Cancer Institute.
There is a great amount of excitement in the ovarian cancer clinical and research communities about the … Read more
Most – and possibly all – ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.
This is the finding of a multicenter study of ovarian cancer genetics led by researchers from Perlmutter Cancer Center … Read more
Don’t delay platinum-based chemotherapy in favor of single-agent non-platinum-based chemotherapy in patients with partially platinum-sensitive ovarian cancer, Italian researchers advised.
Introducing non-platinum chemotherapy to prolong the platinum-free interval (PFI) in patients with progressing ovarian cancer who experience disease recurrence, or … Read more
